These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16883953)

  • 1. [The role of nitric oxide in physiology and pathogenesis of ocular diseases].
    Komaszyło K; Zalewska R; Mariak Z; Wiśniewska RJ
    Klin Oczna; 2006; 108(1-3):103-6. PubMed ID: 16883953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of nitric oxide modulation in ocular diseases.
    Drago F; Bucolo C
    Drug News Perspect; 2010 Sep; 23(7):430-7. PubMed ID: 20862395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saving the nerve from glaucoma: memantine to caspaces.
    Naskar R; Vorwerk CK; Dreyer EB
    Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glaucomatous optic neuropathy: when glia misbehave.
    Neufeld AH; Liu B
    Neuroscientist; 2003 Dec; 9(6):485-95. PubMed ID: 14678581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biosynthesis of nitric oxide and its function in organism].
    Komaszyło K; Zalewska R; Mariak Z; Wiśniewska RJ
    Klin Oczna; 2006; 108(1-3):99-102. PubMed ID: 16883952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part II].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):353-5. PubMed ID: 18260297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ocular hypertension on retinal nitridergic pathway activity.
    Belforte N; Moreno MC; Cymeryng C; Bordone M; Keller Sarmiento MI; Rosenstein RE
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2127-33. PubMed ID: 17460271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal vulnerability to glutamate excitotoxicity in canine glaucoma: induction of neuronal nitric oxide synthase in retinal ganglion cells.
    Franco-Bourland RE; Guízar-Sahagún G; García GA; Odor-Morales A; Alvarez A; Esquivel F; Rodríguez S
    Proc West Pharmacol Soc; 1998; 41():201-4. PubMed ID: 9836292
    [No Abstract]   [Full Text] [Related]  

  • 9. Glial cells and glaucomatous neuropathy.
    Zhong YS; Leung CK; Pang CP
    Chin Med J (Engl); 2007 Feb; 120(4):326-35. PubMed ID: 17374286
    [No Abstract]   [Full Text] [Related]  

  • 10. Combustion smoke exposure induces up-regulated expression of vascular endothelial growth factor, aquaporin 4, nitric oxide synthases and vascular permeability in the retina of adult rats.
    Zou YY; Lu J; Poon DJ; Kaur C; Cao Q; Teo AL; Ling EA
    Neuroscience; 2009 May; 160(3):698-709. PubMed ID: 19285541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: effects of nitric oxide on eye diseases and their treatment.
    Chiou GC
    J Ocul Pharmacol Ther; 2001 Apr; 17(2):189-98. PubMed ID: 11324986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy.
    Toda N; Nakanishi-Toda M
    Prog Retin Eye Res; 2007 May; 26(3):205-38. PubMed ID: 17337232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma.
    Haefliger IO; Dettmann E; Liu R; Meyer P; Prünte C; Messerli J; Flammer J
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S51-8. PubMed ID: 10416747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.
    Neufeld AH
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S129-35. PubMed ID: 10416755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma.
    Neufeld AH
    Brain Res Bull; 2004 Feb; 62(6):455-9. PubMed ID: 15036557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular mechanisms of retinal ischemia].
    Neroev VV; Zueva MV; Kalamkarov GR
    Vestn Oftalmol; 2010; 126(3):59-64. PubMed ID: 20608206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The future started: nitric oxide in glaucoma].
    Stefan C; Dumitrica DM; Ardeleanu C
    Oftalmologia; 2007; 51(4):89-94. PubMed ID: 18543682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of nitric oxide in ophthalmic diseases].
    Gerkowicz M; Kosior-Jarecka E; Kozioł-Montewka M
    Klin Oczna; 2005; 107(7-9):533-6. PubMed ID: 16417016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide as a mediator of glaucoma pathogenesis.
    Sacca S
    Med Sci Monit; 2002 Aug; 8(8):LE33-34. PubMed ID: 12233710
    [No Abstract]   [Full Text] [Related]  

  • 20. RBC NOS: regulatory mechanisms and therapeutic aspects.
    Ozüyaman B; Grau M; Kelm M; Merx MW; Kleinbongard P
    Trends Mol Med; 2008 Jul; 14(7):314-22. PubMed ID: 18539530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.